GLP-1 medical weight loss in Tampa via Ascend Mind and Body: same-week appointments at our Carrollwood office (3971 Moran Rd, Suite 101, 33618) or Florida telehealth follow-ups for established patients. The program runs out of family medicine, not a med-spa: workup before prescription, contraindication screening, real follow-up cadence, and a medical record that connects to the rest of your care. Dr. Jason Saylor, DO is the prescriber. Call (813) 670-3331 or book online.
How GLP-1 weight loss works at the Tampa office
Your first visit is roughly 45 minutes in person at Carrollwood. We cover weight history (when did the trajectory change, what's been tried, what worked and didn't), lifestyle (sleep, activity, eating patterns, stress, full medication list), and a focused exam. Then we order labs: HbA1c and fasting glucose to check for prediabetes or type 2 diabetes, comprehensive metabolic panel for kidney and liver function, lipid panel for the cardiovascular picture, TSH because thyroid disease drives weight changes and is often missed, plus additional markers based on your history.
We screen carefully for contraindications: personal or family history of medullary thyroid carcinoma, MEN2 syndrome, severe gastroparesis, prior pancreatitis, active eating disorder, pregnancy or planned pregnancy. We also screen for sleep apnea, mood disorders, and weight-driving medications already on board (some psychiatric and antidiabetic medications drive weight gain that's worth identifying before adding another medication). The point is to figure out what's actually driving your case before deciding whether GLP-1 is the right tool.
If labs and history support GLP-1 candidacy, we walk through options: branded vs. compounded, semaglutide vs. tirzepatide, what insurance covers, what it doesn't, and the actual self-pay numbers. Side-effect profile honestly - the first eight weeks are typically the hardest, GI side effects are real, titration matters. Patients who do best are the ones who use the medication as a tool, not as the whole program.
Where we are in Tampa
The Tampa office is at 3971 Moran Road, Suite 101, Tampa, FL 33618, in the Carrollwood corridor just east of the Veterans Expressway. From South Tampa via Dale Mabry, expect about 20 minutes northbound. From Westchase or Town N Country via Linebaugh, about 15 minutes east. From New Tampa or Tampa Palms via I-275/Bearss, about 25 minutes west. Surface parking, accessible entrance.
Who we work with in Tampa & nearby
- North Tampa & Carrollwood: 33618, 33625 (Citrus Park), 33624 (Northdale)
- South Tampa & Hyde Park: 33606, 33609, 33611
- Westchase & Town N Country: 33626, 33615
- New Tampa & Tampa Palms: 33647
- Lutz: 33549, 33558
- Brandon corridor: 33510, 33511 (often via telehealth - see GLP-1 in Brandon)
Our prescriber
Dr. Jason Saylor, DO is a board-certified osteopathic family medicine physician with 17 years of clinical experience, serving as Chief Medical Officer at Ascend. His clinical scope explicitly includes weight loss management, chronic disease management (diabetes, hypertension, hyperlipidemia, thyroid disease), and preventive medicine - the full picture that medical weight loss work requires. Dr. Saylor sees Tampa patients in person at the Carrollwood office and via Florida-statewide telehealth. [NEEDED: Saylor GLP-1 prescribing scope confirmation - CMO to confirm preferred GLP-1 protocols, branded vs. compounded approach, and program structure]
Conditions and situations we treat alongside weight management
Medical weight loss work overlaps significantly with chronic disease management. Most Tampa patients we see for GLP-1 evaluation also need to look at:
- Type 2 diabetes with weight management goals - GLP-1 medications often address both indications simultaneously
- Hypertension tied to weight - coordinated medication review and lifestyle work
- Dyslipidemia and metabolic syndrome - lipids often improve markedly with weight loss
- Prediabetes - HbA1c 5.7-6.4%, where intervention can prevent progression
- Fatty liver disease (MASLD) - weight loss is the primary intervention
- Preventive care screenings - weight management is part of cardiovascular risk reduction
Insurance & pricing in Tampa
In-network
Dr. Saylor is currently in-network with Aetna and ChampVA. Credentialing is in process for BCBS, Humana, Medicare, Medicaid (Careplus, Simply Healthcare), TRICARE East, Wellpoint, Oscar Health, and Health Network One. Coverage for GLP-1 medications themselves depends on your plan, your indication (diabetes vs. weight management), and whether your plan covers weight management indications at all.
Self-pay
[NEEDED: GLP-1 self-pay rates - consultation, follow-up, and any program/medication bundling per CMO/billing review]
Also see our nearby weight loss options
- GLP-1 in Wesley Chapel: in-person at the flagship Pasco County office
- GLP-1 in Brandon: Florida telehealth, for men & women in the eastern Hillsborough corridor
- Medical weight loss pillar: full program detail, FAQs, and clinical workup
- TRT in Tampa: when low testosterone is part of the picture for men
- Tampa primary care: full chronic disease management
FAQs about GLP-1 weight loss in Tampa
Where in Tampa do you offer GLP-1 weight loss?
3971 Moran Road, Suite 101, in Carrollwood (33618). Just east of the Veterans Expressway, between Dale Mabry and Florida Avenue. Surface parking, accessible entrance. Florida telehealth follow-ups also available for established patients.
Am I a candidate for a GLP-1?
FDA labeling for GLP-1 weight management generally covers adults with BMI 30+ or BMI 27+ with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, sleep apnea). We confirm eligibility via workup, screen for contraindications, and discuss the full medical picture before any prescription decision.
What labs are involved?
HbA1c, fasting glucose, lipid panel, comprehensive metabolic panel, TSH, and additional markers based on history. We screen for contraindications (medullary thyroid carcinoma history, MEN2, gastroparesis, pancreatitis history) before any prescription.
What's the difference between Wegovy, Ozempic, Mounjaro, and Zepbound?
Semaglutide is the active ingredient in Ozempic (FDA-approved for type 2 diabetes) and Wegovy (FDA-approved for chronic weight management). Tirzepatide is in Mounjaro (T2D) and Zepbound (weight management). The molecule is the same; the brand reflects the FDA-approved indication, which matters for insurance coverage and clinical fit.
Do you offer compounded semaglutide?
[NEEDED: Ascend compounded vs. branded GLP-1 dispensing policy - CMO/billing decision] Either way, we discuss the differences, the trade-offs, and the FDA-approval status of each option with every patient.
How much weight will I lose?
Clinical trials of semaglutide for weight management showed average weight loss of approximately 15% of body weight over 68 weeks; tirzepatide trials showed approximately 20-22%. Those are averages - some patients lose more, some less, some don't respond well. Individual results vary based on dose tolerance, lifestyle integration, baseline metabolic factors, and adherence. [NEEDED: cite STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022)]
What happens if I stop the medication?
Weight regain is common after discontinuation unless lifestyle factors have substantially shifted in the meantime. Trial data on semaglutide showed about two-thirds of weight loss regained within a year of stopping. We treat weight as a chronic condition and work on lifestyle alongside the medication, not after.
Do you take insurance?
Coverage varies by plan and indication. Type 2 diabetes diagnoses generally have better GLP-1 coverage. Weight management coverage is plan-specific and often requires prior authorization. Dr. Saylor is in-network with Aetna and ChampVA, with credentialing in process for several others. We verify benefits before starting.
GLP-1 receptor agonists are FDA-approved prescription medications for chronic weight management or type 2 diabetes when patients meet clinical criteria. Common side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose titration. Serious risks include pancreatitis, gallbladder disease, and possible worsening of certain conditions. Weight loss results vary substantially. This page is informational and does not substitute for a clinical visit. [NEEDED: cite - FDA prescribing information for Wegovy, Zepbound, Ozempic, Mounjaro]